palmitoylethanolamide.com.au
HomeResearchElisabetta 2021

Conjugated Linoleic Acid and Brain Metabolism: A Possible Anti-Neuroinflammatory Role Mediated by PPARα Activation

Elisabetta Murru, Gianfranca Carta, Claudia Manca, Valeria Sogos, Marco Pistis, Miriam Melis, Sebastiano Banni. Front Pharmacol. 2021 Jan 8:11:587140.

ReviewHumansOther animals

Design
Review
Subjects
Not stated in the abstract
Dose used in the study
Not stated in the abstract
Duration
Not stated in the abstract
What was measured
Whether dietary conjugated linoleic acid (CLA) raises brain palmitoylethanolamide and oleoylethanolamide: a review of CLA's binding to PPAR-alpha and its incorporation into brain tissue.

What the authors reported

CLA is taken up and metabolised in brain tissue, where it induces synthesis of the endogenous PPAR-alpha ligands palmitoylethanolamide and oleoylethanolamide, possibly through a positive feedback loop, the authors say. Whether dietary CLA has anti-inflammatory activity in neurological disease needs future study.

Limits of this study

A narrative review with no numbers; it does not test PEA supplementation. The authors declare no commercial or financial relationships.

Source

PubMed 33505308 · doi:10.3389/fphar.2020.587140

Entry checked against the abstract on PubMed on 2026-09-22. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.